AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1754-1611
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo ; volume:15 ; number:1 ; day:21 ; month:10 ; year:2021 ; pages:1-10 ; date:12.2021
Journal of biological engineering ; 15, Heft 1 (21.10.2021), 1-10, 12.2021
- Urheber
-
Cha, Byung-Hyun
Jung, Minjin
Kim, Angela S.
Lepak, Victoria C.
Colson, Brett A.
Bull, David A.
Won, Youngwook
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13036-021-00276-3
- URN
-
urn:nbn:de:101:1-2022011419550073168418
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cha, Byung-Hyun
- Jung, Minjin
- Kim, Angela S.
- Lepak, Victoria C.
- Colson, Brett A.
- Bull, David A.
- Won, Youngwook
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
Antiandrogenic therapy with finasteride attenuates cardiac hypertrophy and left ventricular dysfunction
KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
Roselle attenuates cardiac hypertrophy after myocardial infarction in vivo and in vitro
Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p
Cardiac hypertrophy at autopsy
The orphan receptor TR3 participates in angiotensin II‐induced cardiac hypertrophy by controlling mTOR signalling
Circular RNA-circPan3 attenuates cardiac hypertrophy via miR-320-3p/HSP20 axis
Author Correction: Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
The Kv4 potassium channel modulator NS5806 attenuates cardiac hypertrophy in vivo and in vitro
Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
Antiandrogenic therapy with finasteride attenuates cardiac hypertrophy and left ventricular dysfunction
KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
Roselle attenuates cardiac hypertrophy after myocardial infarction in vivo and in vitro
Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p
Cardiac hypertrophy at autopsy
The orphan receptor TR3 participates in angiotensin II‐induced cardiac hypertrophy by controlling mTOR signalling
Circular RNA-circPan3 attenuates cardiac hypertrophy via miR-320-3p/HSP20 axis
Author Correction: Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
The Kv4 potassium channel modulator NS5806 attenuates cardiac hypertrophy in vivo and in vitro
Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
Antiandrogenic therapy with finasteride attenuates cardiac hypertrophy and left ventricular dysfunction
KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
Roselle attenuates cardiac hypertrophy after myocardial infarction in vivo and in vitro
Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p
Cardiac hypertrophy at autopsy
The orphan receptor TR3 participates in angiotensin II‐induced cardiac hypertrophy by controlling mTOR signalling
Circular RNA-circPan3 attenuates cardiac hypertrophy via miR-320-3p/HSP20 axis
Author Correction: Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway